Skip to main content
NCBI home page
Archives of Disease in Childhood logoLink to Archives of Disease in Childhood
. 2001 Aug;85(2):143–148. doi: 10.1136/adc.85.2.143

Persistent wheezing in infants with an atopic tendency responds to inhaled fluticasone

R Chavasse 1, Y Bastian-Lee 1, H Richter 1, T Hilliard 1, P Seddon 1, G RUSSELL 1
PMCID: PMC1718878  PMID: 11466189

Abstract

BACKGROUND—The role of inhaled corticosteroids for the treatment of wheeze in infancy remains unclear.
AIM—To investigate the effect of inhaled fluticasone on symptoms in a group of wheezy infants who had a high risk of progressing to childhood asthma.
METHODS—A total of 52 infants, under 1 year of age, with a history of wheeze or cough and a history (personal or first degree relative) of atopy were prescribed either 150 µg fluticasone twice daily (group F) or placebo (group P), via metered dose inhaler, for 12 weeks following a two week run in period. Symptoms were scored in a parent held diary and the mean daily symptom score (MDS) and symptom free days (SFD) calculated for each two week period.
RESULTS—Thirty seven infants completed the study. Both MDS and SFD improved significantly between the run in and final two week period in group F, but not group P, with a mean difference in change (95% CI) between groups of 1.12 (0.05 to 2.18) for MDS and median difference of 3.0 (0.002 to 8.0) for SFD.
CONCLUSION—Improvement of clinical symptoms in response to fluticasone can be shown in this high risk group of infants. In the absence of effective alternatives inhaled corticosteroids should be considered in this patient group.



Full Text

The Full Text of this article is available as a PDF (143.3 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Balfour-Lynn I. M. Why do viruses make infants wheeze? Arch Dis Child. 1996 Mar;74(3):251–259. doi: 10.1136/adc.74.3.251. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Balfour-Lynn I. M. Why do viruses make infants wheeze? Arch Dis Child. 1996 Mar;74(3):251–259. doi: 10.1136/adc.74.3.251. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Bertelsen A., Andersen J. B., Busch P., Daugbjerg P., Friis B., Hansen L., Jacobsen S. V., Pelck I., Petersen W., Prahl P. Nebulised sodium cromoglycate in the treatment of wheezy bronchitis. A multicentre double-blind placebo controlled study. Allergy. 1986 May;41(4):266–270. doi: 10.1111/j.1398-9995.1986.tb02027.x. [DOI] [PubMed] [Google Scholar]
  4. Bisgaard H., Gillies J., Groenewald M., Maden C. The effect of inhaled fluticasone propionate in the treatment of young asthmatic children: a dose comparison study. Am J Respir Crit Care Med. 1999 Jul;160(1):126–131. doi: 10.1164/ajrccm.160.1.9811024. [DOI] [PubMed] [Google Scholar]
  5. Bisgaard H., Munck S. L., Nielsen J. P., Petersen W., Ohlsson S. V. Inhaled budesonide for treatment of recurrent wheezing in early childhood. Lancet. 1990 Sep 15;336(8716):649–651. doi: 10.1016/0140-6736(90)92147-a. [DOI] [PubMed] [Google Scholar]
  6. Cade A., Brownlee K. G., Conway S. P., Haigh D., Short A., Brown J., Dassu D., Mason S. A., Phillips A., Eglin R. Randomised placebo controlled trial of nebulised corticosteroids in acute respiratory syncytial viral bronchiolitis. Arch Dis Child. 2000 Feb;82(2):126–130. doi: 10.1136/adc.82.2.126. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Chavasse R. J., Bastian-Lee Y., Richter H., Hilliard T., Seddon P. Inhaled salbutamol for wheezy infants: a randomised controlled trial. Arch Dis Child. 2000 May;82(5):370–375. doi: 10.1136/adc.82.5.370. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Cogswell J. J., Simpkiss M. J. Nebulised sodium cromoglycate in recurrently wheezy preschool children. Arch Dis Child. 1985 Aug;60(8):736–738. doi: 10.1136/adc.60.8.736. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. De Boeck K., Van der Aa N., Van Lierde S., Corbeel L., Eeckels R. Respiratory syncytial virus bronchiolitis: a double-blind dexamethasone efficacy study. J Pediatr. 1997 Dec;131(6):919–921. doi: 10.1016/s0022-3476(97)70044-1. [DOI] [PubMed] [Google Scholar]
  10. Fox G. F., Everard M. L., Marsh M. J., Milner A. D. Randomised controlled trial of budesonide for the prevention of post-bronchiolitis wheezing. Arch Dis Child. 1999 Apr;80(4):343–347. doi: 10.1136/adc.80.4.343. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Furfaro S., Spier S., Drblik S. P., Turgeon J. P., Robert M. Efficacy of cromoglycate in persistently wheezing infants. Arch Dis Child. 1994 Oct;71(4):331–334. doi: 10.1136/adc.71.4.331. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Geller-Bernstein C., Levin S. Nebulised sodium cromoglycate in the treatment of wheezy bronchitis in infants and young children. Respiration. 1982;43(4):294–298. doi: 10.1159/000194497. [DOI] [PubMed] [Google Scholar]
  13. Glass J., Archer L. N., Adams W., Simpson H. Nebulised cromoglycate, theophylline, and placebo in preschool asthmatic children. Arch Dis Child. 1981 Aug;56(8):648–651. doi: 10.1136/adc.56.8.648. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Kraemer R., Graf Bigler U., Casaulta Aebischer C., Weder M., Birrer P. Clinical and physiological improvement after inhalation of low-dose beclomethasone dipropionate and salbutamol in wheezy infants. Respiration. 1997;64(5):342–349. doi: 10.1159/000196702. [DOI] [PubMed] [Google Scholar]
  15. Kraemer R., Graf Bigler U., Casaulta Aebischer C., Weder M., Birrer P. Clinical and physiological improvement after inhalation of low-dose beclomethasone dipropionate and salbutamol in wheezy infants. Respiration. 1997;64(5):342–349. doi: 10.1159/000196702. [DOI] [PubMed] [Google Scholar]
  16. Martinez F. D., Wright A. L., Taussig L. M., Holberg C. J., Halonen M., Morgan W. J. Asthma and wheezing in the first six years of life. The Group Health Medical Associates. N Engl J Med. 1995 Jan 19;332(3):133–138. doi: 10.1056/NEJM199501193320301. [DOI] [PubMed] [Google Scholar]
  17. Martinez F. D., Wright A. L., Taussig L. M., Holberg C. J., Halonen M., Morgan W. J. Asthma and wheezing in the first six years of life. The Group Health Medical Associates. N Engl J Med. 1995 Jan 19;332(3):133–138. doi: 10.1056/NEJM199501193320301. [DOI] [PubMed] [Google Scholar]
  18. Noble V., Ruggins N. R., Everard M. L., Milner A. D. Inhaled budesonide for chronic wheezing under 18 months of age. Arch Dis Child. 1992 Mar;67(3):285–288. doi: 10.1136/adc.67.3.285. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Park E. S., Golding J., Carswell F., Stewart-Brown S. Preschool wheezing and prognosis at 10. Arch Dis Child. 1986 Jul;61(7):642–646. doi: 10.1136/adc.61.7.642. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Pedersen S. Early use of inhaled steroids in children with asthma. Clin Exp Allergy. 1997 Sep;27(9):995–1004. doi: 10.1111/j.1365-2222.1997.tb01247.x. [DOI] [PubMed] [Google Scholar]
  21. Prahl P., Petersen N. T., Hornsleth A. Beta 2-agonists for the treatment of wheezy bronchitis? Ann Allergy. 1986 Dec;57(6):439–441. [PubMed] [Google Scholar]
  22. Richter H., Seddon P. Early nebulized budesonide in the treatment of bronchiolitis and the prevention of postbronchiolitic wheezing. J Pediatr. 1998 May;132(5):849–853. doi: 10.1016/s0022-3476(98)70316-6. [DOI] [PubMed] [Google Scholar]
  23. Roosevelt G., Sheehan K., Grupp-Phelan J., Tanz R. R., Listernick R. Dexamethasone in bronchiolitis: a randomised controlled trial. Lancet. 1996 Aug 3;348(9023):292–295. doi: 10.1016/s0140-6736(96)02285-4. [DOI] [PubMed] [Google Scholar]
  24. Rusconi F., Patria M. F., Cislaghi G. U., Sideri S., Gagliardi L. Total serum IgE and outcome in infants with recurrent wheezing. Arch Dis Child. 2001 Jul;85(1):23–25. doi: 10.1136/adc.85.1.23. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Salmon B., Wilson N. M., Silverman M. How much aerosol reaches the lungs of wheezy infants and toddlers? Arch Dis Child. 1990 Apr;65(4):401–403. doi: 10.1136/adc.65.4.401. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Silverman M., Wilson N. Asthma--time for a change of name? Arch Dis Child. 1997 Jul;77(1):62–65. doi: 10.1136/adc.77.1.62. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Sly P. D., Lanteri C. J., Raven J. M. Do wheezy infants recovering from bronchiolitis respond to inhaled salbutamol? Pediatr Pulmonol. 1991;10(1):36–39. doi: 10.1002/ppul.1950100108. [DOI] [PubMed] [Google Scholar]
  28. Sporik R., Holgate S. T., Cogswell J. J. Natural history of asthma in childhood--a birth cohort study. Arch Dis Child. 1991 Sep;66(9):1050–1053. doi: 10.1136/adc.66.9.1050. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Stick S. M., Burton P. R., Clough J. B., Cox M., LeSouëf P. N., Sly P. D. The effects of inhaled beclomethasone dipropionate on lung function and histamine responsiveness in recurrently wheezy infants. Arch Dis Child. 1995 Oct;73(4):327–332. doi: 10.1136/adc.73.4.327. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Tasche M. J., van der Wouden J. C., Uijen J. H., Ponsioen B. P., Bernsen R. M., van Suijlekom-Smit L. W., de Jongste J. C. Randomised placebo-controlled trial of inhaled sodium cromoglycate in 1-4-year-old children with moderate asthma. Lancet. 1997 Oct 11;350(9084):1060–1064. doi: 10.1016/s0140-6736(97)05333-6. [DOI] [PubMed] [Google Scholar]
  31. Van Bever H. P., Schuddinck L., Wojciechowski M., Stevens W. J. Aerosolized budesonide in asthmatic infants: a double blind study. Pediatr Pulmonol. 1990;9(3):177–180. doi: 10.1002/ppul.1950090310. [DOI] [PubMed] [Google Scholar]
  32. Van Bever H. P., Schuddinck L., Wojciechowski M., Stevens W. J. Aerosolized budesonide in asthmatic infants: a double blind study. Pediatr Pulmonol. 1990;9(3):177–180. doi: 10.1002/ppul.1950090310. [DOI] [PubMed] [Google Scholar]
  33. Williams H., McNicol K. N. Prevalence, natural history, and relationship of wheezy bronchitis and asthma in children. An epidemiological study. Br Med J. 1969 Nov 8;4(5679):321–325. doi: 10.1136/bmj.4.5679.321. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Wilson N. M., Doré C. J., Silverman M. Factors relating to the severity of symptoms at 5 yrs in children with severe wheeze in the first 2 yrs of life. Eur Respir J. 1997 Feb;10(2):346–353. doi: 10.1183/09031936.97.10020346. [DOI] [PubMed] [Google Scholar]
  35. Wilson N. M., Silverman M. Treatment of acute, episodic asthma in preschool children using intermittent high dose inhaled steroids at home. Arch Dis Child. 1990 Apr;65(4):407–410. doi: 10.1136/adc.65.4.407. [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. Wilson N. M. The significance of early wheezing. Clin Exp Allergy. 1994 Jun;24(6):522–529. doi: 10.1111/j.1365-2222.1994.tb00949.x. [DOI] [PubMed] [Google Scholar]
  37. Wilson N., Sloper K., Silverman M. Effect of continuous treatment with topical corticosteroid on episodic viral wheeze in preschool children. Arch Dis Child. 1995 Apr;72(4):317–320. doi: 10.1136/adc.72.4.317. [DOI] [PMC free article] [PubMed] [Google Scholar]
  38. de Benedictis F. M., Martinati L. C., Solinas L. F., Tuteri G., Boner A. L. Nebulized flunisolide in infants and young children with asthma: a pilot study. Pediatr Pulmonol. 1996 May;21(5):310–315. doi: 10.1002/(SICI)1099-0496(199605)21:5<310::AID-PPUL6>3.0.CO;2-Q. [DOI] [PubMed] [Google Scholar]
  39. de Blic J., Delacourt C., Le Bourgeois M., Mahut B., Ostinelli J., Caswell C., Scheinmann P. Efficacy of nebulized budesonide in treatment of severe infantile asthma: a double-blind study. J Allergy Clin Immunol. 1996 Jul;98(1):14–20. doi: 10.1016/s0091-6749(96)70221-x. [DOI] [PubMed] [Google Scholar]
  40. de Blic J., Delacourt C., Le Bourgeois M., Mahut B., Ostinelli J., Caswell C., Scheinmann P. Efficacy of nebulized budesonide in treatment of severe infantile asthma: a double-blind study. J Allergy Clin Immunol. 1996 Jul;98(1):14–20. doi: 10.1016/s0091-6749(96)70221-x. [DOI] [PubMed] [Google Scholar]

Articles from Archives of Disease in Childhood are provided here courtesy of BMJ Publishing Group

RESOURCES